Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The N-type voltage-gated calcium channel subunit alpha-1B (CaV2.2, encoded by the CACNA1B gene) is the primary pore-forming subunit of the N-type calcium channel, a high-voltage-activated ion channel predominantly found in presynaptic nerve terminals and neuroendocrine cells. It is integral to synaptic transmission, controlling the entry of calcium ions into neurons to trigger neurotransmitter release. Structurally, the alpha-1B subunit forms a central pore surrounded by four homologous domains, each consisting of six transmembrane segments, and associates with several auxiliary subunits (α2δ, β, sometimes γ) to modulate function and expression. These channels play a key role in pain pathways and are pharmacologically targeted by peptide toxins and the drug ziconotide for severe chronic pain, with emerging research into their involvement in various neurological disorders[1][2][3][4][5][8].
Blockage of calcium influx into neuronal terminals; Inhibition of neurotransmitter release (especially pain neurotransmitters); Disruption of synaptic transmission in pain pathways[1][2]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-type voltage-gated calcium channel subunit alpha-1B (CaV2.2 (or α1B)).